Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000219103 | SCV000277000 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-04-03 | criteria provided, single submitter | clinical testing | The p.N1052D variant (also known as c.3154A>G), located in coding exon 9 of the BRCA1 gene, results from an A to G substitution at nucleotide position 3154. The asparagine at codon 1052 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is highly conserved on limited sequence alignment. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV000219103 | SCV003847299 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |